 Anixa Biosciences, Inc. NASDAQ: ANIX, a biotechnology company focused on harnessing the bodys immune system in the fight against cancer, today announced the commercial launch of its CchekTM Prostate Cancer Confirmation test CchekTM PCC, the first test developed with the CchekTM artificial intelligence driven, flow cytometry based, liquid biopsy technology platform. 